Stephen Pandol
Cedars-Sinai Medical Center
Appearances
- DateMay 6, 2023A translational symposium that focuses on the evolving role of artificial intelligence and machine learning in early detection of pancreatic cancer, genetic testing and novel molecular diagnostic bio-markers and recent advances in digital tools that can be applied to enhance early detection and imp…
Moderators
The Ohio State UniversityCedars-Sinai Medical Center - DateMay 9, 2023BACKGROUND: Endoscopic Snare Papillectomy (ESP) is a minimally invasive option for the management of noninvasive ampullary adenomas…
Presenter
Speakers
Indiana University School of MedicineNIDDK/NIHUniversity of FloridaOhio State UniversityCedars-Sinai Medical CenterStanford UniversityMayo ClinicUPMC - DateMay 8, 2023BACKGROUND: Around 15% of acute pancreatitis patients develop necrosis of the pancreatic/peri-pancreatic tissue resulting in necrotic debris surrounded by a wall of granulation tissue called “walled-off pancreas necrosis” (WON)…
- DateMay 8, 2023Early-onset colorectal cancer (CRC diagnosed before age 50) has risen worldwide, with an increasing number of survivors of reproductive age. We aimed to investigate the risk of adverse pregnancy and neonatal outcomes among early-onset CRC survivors…
- DateMay 7, 2023Diabetes mellitus (DM) and prediabetes are common complications of acute pancreatitis (AP) and have aroused general concern in recent years. The underlying mechanisms need to be addressed…
Presenter
Speakers
Cedars-Sinai Medical Center - DateMay 9, 2023BACKGROUND AND AIMS: Currently, most patients with branch duct intraductal papillary mucinous neoplasms (BD-IPMN) are offered indefinite surveillance, resulting in health care costs with questionable benefits regarding cancer prevention…
Presenter
Speakers
- DateMay 7, 2023BACKGROUND: Pancreatic cancer (PC) features highly proliferative cancer cells and a dense stroma modulating tumor growth. Due to the invasive behavior of PC and the lack of effective treatments, there is a pressing need to develop therapies targeted at tumorigenic events to slow down PC progression…
Presenter
Speakers
Cedars-Sinai Medical Center - DateMay 7, 2023BACKGROUND: Pancreatic cancer (PC) features highly proliferative cancer cells and a dense stroma modulating tumor growth. Due to the invasive behavior of PC and the lack of effective treatments, there is a pressing need to develop therapies targeted at tumorigenic events to slow down PC progression…
Presenter
- DateMay 21, 2024SOCIETY: AGA A translational symposium that focuses on the evolving role of artificial intelligence and machine learning in early detection of pancreatic cancer, genetic testing and novel molecular diagnostic bio-markers and recent advances in digital tools that can be applied to enhance early dete…
Moderators
Massachusetts General HospitalCedars-Sinai Medical Center - DateMay 21, 2024BACKGROUND: Obesity and type-2 diabetes mellitus (T2DM) are substantial risk factors for pancreatic ductal adenocarcinoma (PDAC). Both obesity and T2DM are often linked to aberrant insulin processing in β cells and altered liver lipid metabolism…
Presenter
Speakers
Cedars-Sinai Medical Center - DateMay 21, 2024BACKGROUND: Pancreatic ductal adenocarcinoma (PC) is a deadly cancer with a rapidly rising incidence and a low 5-year relative survival rate…
Presenter
Speakers
- DateMay 21, 2024OBJECTIVE. Chronic Pancreatitis (CP) has a detrimental impact on quality of life (QOL). However, with one exception, literature on QOL in CP is limited to cross-sectional data, hindering our ability to understand temporal changes and identify potentially modifiable factors…
Presenter
UPMCSpeakers
NIDDK/NIHUniversity of MinnesotaUniversity of FloridaOhio State UniversityStanford UniversityCedars-Sinai Medical CenterMayo Clinic - DateMay 6, 2025This session will focus on the pathogenesis of acute pancreatitis from three perspectives: translational, clinical and population medicine…
Moderators
Cedars-Sinai Medical CenterUniversity of Michigan